Ombitasvir/paritaprevir/ritonavir

Property	Value
rdf:type	World Health Organization essential medicine owl:NamedIndividual Combination drug NS5A inhibitor NS3/4A protease inhibitor AbbVie brand HIV protease inhibitor Drug granted breakthrough therapy designation
rdfs:label	Ombitasvir/paritaprevir/ritonavir
owl:sameAs	dbr:Ombitasvir/paritaprevir/ritonavir
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:NS5A_inhibitors http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/WHO_Model_List_of_Essential_Medicines http://en.wikipedia.org/wiki/Category:NS3/4A_protease_inhibitors http://en.wikipedia.org/wiki/Category:Combination_drugs http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Dasabuvir http://en.wikipedia.org/wiki/Category:HIV_protease_inhibitors http://en.wikipedia.org/wiki/Category:AbbVie_brands
skos:prefLabel	Ombitasvir/paritaprevir/ritonavir
skos:altLabel	Ombitasvir, paritaprevir and ritonavir Ombitasvir/paritaprevir/ritonavir/dasabuvir ombitasvir/paritaprevir/ritonavir
clgo:alternativeName	Viekira Pak, Viekira XR, Holkira Pak, others Viekira Pak (withdasabuvir), Technivie, Viekirax, others
clgo:casNumber	1799419-19-4
clgo:chEBI	85177 90919
clgo:kegg	D10582 D10745
clgo:medlinePlus	a614057 a615036
clgo:pubchem	254741544
is clgo:drugs.com of	Dasabuvir

About: clgr:Ombitasvir/paritaprevir/ritonavir